NCT00005596
Clinical Trial Information
Trial Number: NCT00005596 (ClinicalTrials.gov)
Disease Type:
- Hematopoietic Neoplasm/Leukemia - Acute Lymphoblastic Leukemia
Trial Title:
ALinC 17: Protocol for Patients With Newly Diagnosed Standard Risk Acute Lymphoblastic Leukemia (ALL): A Phase III Study
Study ID:
POG-9905
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Datasets Linked to Trial
| Title | Description |
|---|---|
| 31728054-D2 | 31728054-D2: This is 1 of 2 datasets linked to PMID 31728054, an analysis of patients enrolled on POG-9904 and POG-9905, the low-risk and standard-risk cohorts of the POG-9900 classification trial. This dataset provides information on the primary outcome, treatment group, baseline characteristics, disease-free events, and minimal residual disease at the end of induction. |
| 31728054-D1 | 31728054-D1: This is 1 of 2 datasets linked to PMID 31728054, an analysis of patients enrolled on POG-9904 and POG-9905, the low-risk and standard-risk cohorts of the POG-9900 classification trial. This dataset provides the information for generating the consort diagram of patient enrollment. This dataset also includes limited data from patients enrolled on the high-risk cohort, POG-9906. |
Accessibility | Disclaimer | FOIA | HHS Vulnerability Disclosure | Privacy & Security
U.S. Department of Health and Human Services | National Institutes of Health | National Cancer Institute | USA.gov
NIH…Turning Discovery Into Health®